June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Longitudinal Changes in the Central Visual Field and Risk of Visual Acuity Loss in Glaucoma
Author Affiliations & Notes
  • Tais Estrela
    Ophthalmology, Duke University, Durham, North Carolina, United States
  • Alessandro A Jammal
    Ophthalmology, Duke University, Durham, North Carolina, United States
  • Eduardo Bicalho Mariottoni
    Ophthalmology, Duke University, Durham, North Carolina, United States
  • Leonardo Shigueoka
    Ophthalmology, Duke University, Durham, North Carolina, United States
  • Felipe A Medeiros
    Ophthalmology, Duke University, Durham, North Carolina, United States
  • Footnotes
    Commercial Relationships   Tais Estrela, None; Alessandro Jammal, None; Eduardo Mariottoni, None; Leonardo Shigueoka, None; Felipe Medeiros, Aeri Pharmaceuticals (C), Allergan (C), Allergan (F), Annexon (C), Biogen (C), Carl Zeiss Meditec (C), Carl Zeiss Meditec (F), Galimedix (C), Google Inc. (F), Heidelberg Engineering (F), IDx (C), nGoggle Inc. (P), Novartis (F), Reichert (C), Reichert (F), Stealth Biotherapeutics (C)
  • Footnotes
    Support  Supported in part by National Institutes of Health/National Eye Institute grant EY029885 and EY031898 (FAM).
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 632. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Tais Estrela, Alessandro A Jammal, Eduardo Bicalho Mariottoni, Leonardo Shigueoka, Felipe A Medeiros; Longitudinal Changes in the Central Visual Field and Risk of Visual Acuity Loss in Glaucoma. Invest. Ophthalmol. Vis. Sci. 2021;62(8):632.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To assess whether longitudinal changes in central visual field increase the risk of visual acuity (VA) loss in patients with Primary Open Angle Glaucoma (POAG).

Methods : VA loss was defined as a loss of 0.2 logarithm of the minimum angle of resolution (logMAR) or more in 2 consecutive exams. The mean value of the 4 innermost paracentral point locations from the total deviation (TD) plot of a 24-2 standard automated perimetry (SAP) test, threat to fixation area (TTF), was calculated and a joint longitudinal survival models were used to evaluate the rates of changes in the TTF area for predicting VA loss over time, adjusting for confounding variables, such SAP mean deviation (MD), age and central corneal thickness (CCT) at baseline, and intraocular pressure (IOP) measurement during follow-up. A separated analysis was performed in a subgroup that included only pseudophakic eyes.

Results : This study included 4,131 SAP tests and 17,704 clinical visits of 1,207 eyes of 900 POAG patients followed for an average of 4.0 ± 3.2 years. The rates of change of paracentral points in TD plot were significantly predictive of VA loss with an increase of 2.6-times the risk of developing VA loss for each 1 dB/year decrease in the slope (HR 2.56, CI, 1.73, 3.82; P < 0.001), after adjusting for age, SAP MD and CCT at baseline, and for IOP measurements during follow-up. The risk for VA loss was also higher for the pseudophakic eyes. For this group, rates of change on mean TD of the 4 central points were associated with VA loss with a HR of 4.63 (95% CI:2.38, 8.93; P < 0.001) the multivariable analysis.

Conclusions : In our study longitudinal changes on the mean of 4 central points from SAP TD was predictive of development of VA loss in glaucoma patients and should be included in the assessment of risk for visual impairment.

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×